 |
| Ellen Bubrick, MD |
Ellen Bubrick, MD, of the Department of Neurology, received a two-year, $250,000 Citizens United for Research in Epilepsy (CURE) Epilepsy Catalyst Award to investigate optimal dosing for transcranial ultrasound for epilepsy trials.
The CURE Epilepsy Catalyst Award supports the development of data necessary to advance ideas toward larger funding opportunities.
As a clinician-scientist at the Brigham and Harvard Medical School, Bubrick focuses her research on non-pharmacologic treatments for drug resistant epilepsy. She has pioneered a potential treatment for epilepsy using low intensity focused ultrasound.
CURE Epilepsy was first started in 1998 by founder Susan Axelrod and a group of parents who had children with epilepsy. Since it began, the organization has raised more than $90 million to fund epilepsy research.
